FDA label expansion makes selumetinib the second MEK inhibitor approved for adults with neurofibromatosis type 1-associated ...

AstraZeneca receives FDA approval for Koselugo to treat adults with NF1 and inoperable plexiform neurofibromas, backed by ...

AstraZeneca AZN announced that the FDA has approved its oral, selective MEK inhibitor, Koselugo (selumetinib), for expanded ...

PHILADELPHIA (WPVI) -- There's no cure for neurofibromatosis (NF), and it's been said that the rare genetic disorder is becoming more common. Now a local mother, who was born with the rare disease, is ...

Alexion’s Koselugo approved in US for adults with neurofibromatosis type 1: Cambridge, UK Friday, November 21, 2025, 09:00 Hrs [IST] Alexion, AstraZeneca Rare Disease’s Koselu ...

Q: A doctor said the rashes on my son's back were “coffee spots” and that meant he might have neurofibromatosis. I read there is a new treatment for this condition; is it a cure? A: Café-au-lait spots ...

CLEVELAND — At age 14, he became the Cavaliers' NBA Draft Lottery lucky charm. Nick Gilbert and his signature bow tie, a symbol of courage and strength, which is something he and others battling ...

In most cases, a diagnosis of NF1 is made through a clinical diagnosis based on the presence of two or more of the six NIH diagnostic criteria for the disorder. However, sometimes a diagnosis of NF1 ...

Because NF1 is an unpredictable disorder, it varies widely in severity – even among two people in the same family. Some people with NF1 may be completely unaware that they are affected, experiencing ...

A Pensole Lewis College Detroit student works on designing footwear. The Foot Locker Footwear Creation Stu/deo was opened in February, expanding PLC Detroit’s offerings for students interested in ...